Company news

Cantourage Group SE news in 2026

Cantourage Group SE's news releases, calls and decks from 2026, newest first.

View company

Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines

September 11, 2026

Cantourage Group SE: Early Departure of the Chairman of the Management Board

September 10, 2026

Cantourage Publishes Initial Guidance for Financial Year 2026

August 31, 2026

Cantourage Group SE: Cantourage Group SE Publishes Initial Guidance for Financial Year 2026

August 31, 2026

Cantourage Group SE increases EBITDA by 45 percent in the second quarter of 2026 – strategic focus on high-margin business pays off

August 13, 2026

Cantourage welcomes clarification on the implementation of the German GKV-FinStG

August 7, 2026

Cantourage Launches Proprietary Medical Cannabis Brand gramz. in Germany

July 15, 2026

Cantourage Group SE: Monique Jaqqam, Acceptance of the granting of 25,000 stock options (subscription rights to shares of Cantourage Group SE; ISIN: DE000A3DSV01) under the “Cantourage...

June 5, 2026

Cantourage Group SE: Philip Schetter, Acceptance of the granting of 25,000 stock options (subscription rights to shares of Cantourage Group SE; ISIN: DE000A3DSV01) under the “Cantourage...

June 5, 2026

Cantourage Group SE // Cantourage Significantly Increases Profitability in the First Quarter of 2026

May 11, 2026

Cantourage Group SE: U.S. Cannabis Rescheduling Highlights Global Growth Potential – Europe Comes into Focus

April 24, 2026

Cantourage Group SE publishes preliminary figures for 2025 – Revenue rises to EUR 92.8 million

March 17, 2026

Decks in 2026